Failure of Omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy

被引:0
|
作者
Gomis, V. Soriano [1 ]
Delgado, P. Gonzalez [1 ]
Hernandez, E. Niveiro [1 ]
机构
[1] Gen Hosp Univ Alicante, Secc Alergia, Alicante 0310, Spain
关键词
immunotherapy; omalizumab; anaphylactic reaction; bee venom;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:225 / 226
页数:2
相关论文
共 50 条
  • [31] Omalizumab is effective as add-on treatment in a patient with systemic mastocytosis (SM) and recurrent anaphylaxis during venom immunotherapy (VIT)
    Jandus, P.
    Hausmann, O.
    Haeberli, G.
    Mueller, U.
    Helbling, A.
    ALLERGY, 2010, 65 : 567 - 567
  • [32] Ultrarush venom desensitisation after systemic reactions during conventional venom immunotherapy
    Patella, V
    Florio, G.
    Giuliano, A.
    Oricchio, C.
    ALLERGY, 2013, 68 : 495 - 496
  • [33] Ultrarush venom desensitization after systemic reactions during conventional venom immunotherapy
    Oren, Eyal
    Chegini, Soheil
    Hamilos, Daniel L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2006, 97 (05) : 606 - 610
  • [34] Successful Pretreatment with Omalizumab in Anaphylactic Shock Caused By Bee Venom Immunotherapy
    San Francisco, Arturo Ruiz
    Rondon Segovia, Carmen
    Munoz Daga, Oliver
    Molina, Ana
    Dolores Canamero, Maria
    Mayorga, Cristobalina
    Torres, Maria J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB151 - AB151
  • [35] Treatment failure in bee venom immunotherapy: is it only Api m 10?
    Arzt-Gradwohl, L.
    Cerpes, U.
    Koch, L.
    Laipold, K.
    Vollmann, J.
    Binder, B.
    Sturm, G.
    ALLERGOLOGIE, 2021, 44 (02) : 154 - 155
  • [36] Omalizumab as a premedication in venom immunotherapy: When is it indicated in systemic mastocytosis?
    Yegit, O. O.
    Demir, S.
    Unal, D.
    Colakoglu, B.
    Buyukozturk, S.
    Gelincik, A.
    ALLERGY, 2019, 74 : 525 - 526
  • [37] SYSTEMIC REACTIONS TO HYMENOPTERA VENOM IMMUNOTHERAPY
    YOULTEN, LJF
    ATKINSON, B
    LEE, TH
    CLINICAL AND EXPERIMENTAL ALLERGY, 1994, 24 (02): : 189 - 189
  • [38] High efficacy and absence of severe systemic reactions after venom immunotherapy
    Carballada, F
    Martín, S
    Boquete, M
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2003, 13 (01) : 43 - 49
  • [39] IGE AND IGG ANTIBODY-RESPONSE TO PURIFIED BEE-VENOM ANTIGENS AND PEPTIDES IN 4 PATIENTS WHO HAD ADVERSE REACTIONS TO IMMUNOTHERAPY
    KEMENY, DM
    KAGEYSOBOTKA, A
    LICHTENSTEIN, LM
    LESSOF, MH
    CLINICAL ALLERGY, 1988, 18 (01): : 79 - 84
  • [40] Release of mediators in patients with systemic anaphylactic reactions (SAR) due to immunotherapy (IT) with bee venom.
    Gniazdowska, B
    EberleinKonig, B
    Przybilla, B
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 608 - 608